NEW YORK, April 13 (Reuters) - Anika Therapeutics
ANIK.O reached a settlement with Caligan Partners that
includes adding one of the activist investor's proposed director
candidates to its board.
The biotechnology company, which makes osteoarthritis knee
pain relief injection treatments, said on Thursday it is
appointing former Johnson & Johnson JNJ.N executive Gary
Fischetti as a director and is expanding the size of the board
to eight members.
(Reporting by Svea Herbst-Bayliss)
((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters
Messaging: svea.herbst.thomsonreuters.com@reuters.net))